Primary periodic paralysis is a rare genetic condition that is characterized by attacks of muscle weakness and temporary paralysis.
 ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌
Trouble viewing this e-mail? Please click here to view in your browser.
PRIMARY PERIODIC PARALYSIS
(PPP) CAN BE A PROGRESSIVE
AND DEBILITATING GENETIC
CONDITION1,2
PPP may be challenging to diagnose because symptoms can mimic other disorders, such as depression, stroke,
or a neuromuscular junction disorder1,3
PPP may lead to progressive Permanent Muscle Weakness†2,3
PPP can be incapacitating, physically disabling, and unpredictable, impairing patients’ ability to engage in everyday activities.†2,3
* Based on a survey of 137 patients aged 19-84 years with a diagnosis of Hyperkalemic Periodic Paralysis who were invited through the Internet or through one of several healthcare institutions worldwide.2
Contact your Area Business Specialist
[First, Last - ABS@strongbridgebio.com]
to schedule a peer-to-peer discussion
with an expert.
References: 1. Statland JM, Fontaine B, Hanna MG, et al. Review of the diagnosis and treatment of periodic paralysis. Muscle Nerve. 2018;57:522-530. 2. Charles G, Zheng C, Lehmann-Horn F, Jurkatt-Rott K, Levitt J. Characterization of hyperkalemic periodic paralysis: a survey of genetically diagnosed individuals. J Neurol. 2013;260:2606-2613. 3. Cavel-Greant D, Lehmann-Horn F, Jurkat-Rott K. The impact of permanent muscle weakness on quality of life in periodic paralysis: a survey of 66 patients. Acta Myol. 2012;31:126-133.
This message was sent by: Strongbridge Biopharma • 900 Northbrook Drive, Suite 200 • Trevose, PA 19053
This message and any attachments are for the designated recipient only and may contain privileged, proprietary, or otherwise private information. If you have received this in error, please notify the sender immediately and delete this message. Any other use of this email is prohibited.
Unsubscribe from this list.
Strongbridge Biopharma
www.strongbridgebio.com
© 2018 Strongbridge Biopharma plc
STRONGBRIDGE BIOPHARMA® is a registered trademark of the Strongbridge Biopharma plc. companies, which include Strongbridge Ireland Limited and Strongbridge U.S. Inc.
KEV-0396 07/2018